Cargando…
Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome
INTRODUCTION: Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by loss of expression of paternal chromosome 15q11.2-q13 genes. Individuals with PWS exhibit unique physical, endocrine, and metabolic traits associated with severe obesity. Identifying liver steatosis in PWS is chall...
Autores principales: | Pascut, Devis, Giraudi, Pablo J., Banfi, Cristina, Ghilardi, Stefania, Tiribelli, Claudio, Bondesan, Adele, Caroli, Diana, Minocci, Alessandro, Grugni, Graziano, Sartorio, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684934/ https://www.ncbi.nlm.nih.gov/pubmed/38034016 http://dx.doi.org/10.3389/fendo.2023.1254778 |
Ejemplares similares
-
Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader–Willi Syndrome and Non-Syndromic Obesity
por: Pratama, Muhammad Yogi, et al.
Publicado: (2020) -
Differences in circulating microRNA signature in Prader–Willi syndrome and non-syndromic obesity
por: Pascut, Devis, et al.
Publicado: (2018) -
Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome
por: Paolo, Marzullo, et al.
Publicado: (2020) -
Growth hormone therapy for Prader–willi syndrome: challenges and solutions
por: Grugni, Graziano, et al.
Publicado: (2016) -
Predictive factors of responsiveness to a body weight reduction program in Prader–Willi patients at 6 years of follow-up
por: Lazzer, Stefano, et al.
Publicado: (2022)